WHITEHAWK THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $81.83M.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was -$171.00K.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $94.55M.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2022-09-30 was $72.18M.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2025 was $94.38M.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2022 was $72.18M.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2020 was $9.34M.
- WHITEHAWK THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2018 was $48.12M, a 29.48% increase from fiscal 2017.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $81.83M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $94.38M 10-K · filed 2026-03-12 | |
| 2025-06-30 | -$171.00K 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $94.55M 10-Q · filed 2026-08-06 | |
| 2022-12-31 | $72.18M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $72.18M 10-Q · filed 2023-11-08 | |
| 2021-06-30 | $4.00 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $4.00 10-Q · filed 2021-08-11 | |
| 2020-12-31 | $9.34M 10-K · filed 2021-03-11 | |
| 2020-09-30 | $9.34M 10-Q · filed 2020-11-10 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $48.12M 10-K · filed 2020-03-16 |
| 2018-09-30 | $6.21M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $41.91M 10-Q · filed 2019-11-07 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $37.16M 10-K · filed 2019-03-07 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | |
| 2017-03-31 | $37.16M 10-Q · filed 2017-05-15 | |
| 2007-12-31 | $50.00K 10-Q · filed 2014-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |